High-purity biomaterials for medical and pharma.
Canadian origin. | Regional production. | Supply resilience.
The biomaterials we produce
| Chitin | Chitosan | Chitosan hemostatic | Derivatives and nanocrystals |
|---|---|---|---|
| Biodegradable | High-Strength | Circular | Biodegradable | Antimicrobial | High-Performance | Hemostatic | Nanofibrous | Antimicrobial | Biodegradable | High-Performance | Circular |
| Download our product catalogue. |
Medical & pharma applications
-
The enhanced permeability and low viscosity of our biomaterials make them ideal for skin, nasal, and ocular formulations.
-
Our biomaterials form stable complexes with DNA/RNA while maintaining low cytotoxicity.
-
Our biomaterials can be used in hydrogels and films to promote fibroblast proliferation, collagen synthesis, and antimicrobial protection.
-
Our biomaterials can function as a biodegradable scaffold with tunable mechanical properties. They can be used for cartilage, bone, and skin regeneration.
-
Our chitosan biomaterials can be incorporated into tablets, capsules, and coatings to enhance stability and bioavailability.
-
Our biomaterials can act as hemostatic agents and bioactive coatings for implants.
Our circular production
1. High quality Atlantic shell feedstock
2. MCE process platform
3. Advanced marine biopolymer materials
4. Priority pathways and end market
Key differentiators
Atlantic marine byproducts
Industrial infrastructure and feedstock control
Multiple product pathways
Canadian IP and production